Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Sensyne Health stock

SENS.L
GB00BYV3J755
A2N38D

Price

0.00
Today +/-
+0
Today %
+0 %

Sensyne Health stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Sensyne Health stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Sensyne Health stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Sensyne Health stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Sensyne Health's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Sensyne Health Stock Price History

DateSensyne Health Price
6/17/20220.00 undefined
6/16/20220.01 undefined

Sensyne Health Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Sensyne Health, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Sensyne Health from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Sensyne Health’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Sensyne Health. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Sensyne Health’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Sensyne Health’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Sensyne Health’s growth potential.

Sensyne Health Revenue, EBIT and net profit per share

DateSensyne Health RevenueSensyne Health EBITSensyne Health Net Income
2026e143.63 M undefined76.92 M undefined756.09 undefined
2025e114 M undefined43.25 M undefined1,360.19 undefined
2024e75.76 M undefined24.56 M undefined2,471.43 undefined
2023e54.06 M undefined10.02 M undefined100,471.27 undefined
2022e27.24 M undefined-9.07 M undefined-92,418.1 undefined
20219.1 M undefined-26.91 M undefined-27.52 M undefined
20202.05 M undefined-21.04 M undefined-21.84 M undefined
2019140,000 undefined-15.67 M undefined-21.93 M undefined
201880,000 undefined-7.25 M undefined-49.84 M undefined

Sensyne Health Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20182019202020212022e2023e2024e2025e2026e
0029275475114143
---350.00200.00100.0038.8952.0025.44
--50.0055.5618.529.266.674.393.50
001500000
-49-21-21-2700000
--57.14-28.57-----
94.78119.02129.24139.2200000
---------
Details

Keystats

ⓘ

Revenue and Growth

The Sensyne Health Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Sensyne Health is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (k)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (k)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (k)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
2018201920202021
       
4.5449.2531.6623.57
0.040.071.045.41
0.190.542.091.66
0000
4.150.380.741.08
8.9250.2435.5331.72
0.12.483.042.49
0.1100.472.32
0000
4.7118.0714.925.45
0000
0000
4.9220.5518.4130.26
13.8470.7953.9461.98
       
109.912.8612.8616.48
059.4859.4891.36
-27.84-6.91-28.51-55.19
-69,850-203090
0000
12.2165.4143.8652.74
0.421.24.073.15
0.761.662.993.77
450500870260
0000
0240390390
1.633.68.327.57
01.771.721.65
0000
003040
01.771.751.69
1.635.3710.079.26
13.8470.7853.9362
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Sensyne Health provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Sensyne Health's financial health and stability.

Assets

Sensyne Health's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Sensyne Health must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Sensyne Health after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Sensyne Health's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (k)NON-CASH ITEM (k)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2018201920202021
-7-18-22-28
1345
0000
01,0001,000-3,000
-2,00001,0001,000
0000
0000
-8-14-14-25
0-2-2-5
0-2-2-8
000-2
0000
0000
1064027
1061025
--2.00--1.00
0000
144-17-8
0000
0000

Sensyne Health stock margins

The Sensyne Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sensyne Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sensyne Health.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Sensyne Health's sales revenue. A higher gross margin percentage indicates that the Sensyne Health retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Sensyne Health's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Sensyne Health's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Sensyne Health's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Sensyne Health. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Sensyne Health's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Sensyne Health Margin History

Sensyne Health Gross marginSensyne Health Profit marginSensyne Health EBIT marginSensyne Health Profit margin
2026e64.95 %53.56 %0 %
2025e64.95 %37.94 %0 %
2024e64.95 %32.42 %0 %
2023e64.95 %18.53 %0.19 %
2022e64.95 %-33.29 %-0.34 %
202164.95 %-295.71 %-302.42 %
202056.59 %-1,026.34 %-1,065.37 %
2019-28.57 %-11,192.86 %-15,664.29 %
2018-137.5 %-9,062.5 %-62,300 %

Sensyne Health Stock Sales Revenue, EBIT, Earnings per Share

The Sensyne Health earnings per share therefore indicates how much revenue Sensyne Health has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Sensyne Health earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Sensyne Health's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Sensyne Health’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Sensyne Health's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Sensyne Health Revenue, EBIT and net profit per share

DateSensyne Health Sales per ShareSensyne Health EBIT per shareSensyne Health Earnings per Share
2026e0.86 undefined0 undefined0 undefined
2025e0.68 undefined0 undefined0 undefined
2024e0.46 undefined0 undefined0 undefined
2023e0.32 undefined0 undefined0 undefined
2022e0.16 undefined0 undefined-0 undefined
20210.07 undefined-0.19 undefined-0.2 undefined
20200.02 undefined-0.16 undefined-0.17 undefined
20190 undefined-0.13 undefined-0.18 undefined
20180 undefined-0.08 undefined-0.53 undefined

Sensyne Health business model

Sensyne Health PLC is a British company specializing in artificial intelligence (AI) and digital health solutions. It was founded in 2018 and is headquartered in Oxford, UK. History: Sensyne Health was founded by Lord Drayson, a British entrepreneur and former Minister for Science and Innovation. The company is based on the belief that the application of AI technologies in the healthcare industry can help improve medical care, make the healthcare system more efficient, and ultimately save lives. Business model: Sensyne Health offers a range of products and services based on AI technologies. The key business areas include: - Clinical research: Sensyne Health works closely with national health authorities and various hospitals to collect and analyze data that can be used in the development of new treatment options and the improvement of diagnostic processes. - Digital patient monitoring: The company develops advanced sensors and devices that allow doctors and nurses to monitor the health status of patients in real-time. By using AI algorithms, health problems can be detected and treated early. - AI-based analysis: Sensyne Health has extensive experience in applying AI technologies to medical data. The company uses its expertise to conduct complex data analysis that helps doctors and researchers gain new insights into diseases and their treatment options. Products: Sensyne Health offers a variety of products and solutions tailored to the needs of the healthcare industry. Here are some of the key products that the company offers: - Patient data platform: A cloud-based platform that allows hospitals and research institutions to collect, store, and analyze patient data. The use of AI algorithms automates and accelerates data analysis. - Hospital collaborations: Sensyne Health works with various hospitals in the UK and other countries to collect and analyze patient data. The data is then shared in anonymized form with researchers and life science companies to develop new insights and treatment options. - AI-based patient monitoring: Sensyne Health has developed a range of devices and sensors that allow doctors and nurses to monitor the health status of patients in real-time. The data is automatically evaluated, and the results are transmitted to the medical staff to quickly respond to changes in the patient's condition. Conclusion: Sensyne Health is a leading provider of AI-based solutions for the healthcare industry. The company specializes in data collection, analysis, and the development of new treatment options. Through its collaborations with hospitals and government agencies, Sensyne Health has access to a large amount of data that can lead to new insights and improve medical care in the future. Answer: Sensyne Health PLC is a British company specializing in artificial intelligence (AI) and digital health solutions. It was founded in 2018 and is headquartered in Oxford, UK. The company was founded by Lord Drayson, and it aims to use AI technologies to improve medical care, make healthcare more efficient, and save lives. Sensyne Health offers products and services in clinical research, digital patient monitoring, and AI-based analysis. The company's products include a patient data platform, collaborations with hospitals, and AI-based patient monitoring devices. Sensyne Health is focused on collecting and analyzing data to develop new treatment options and improve healthcare in the future. Sensyne Health is one of the most popular companies on Eulerpool.com.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Sensyne Health Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Sensyne Health historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Sensyne Health shares outstanding

The number of shares was Sensyne Health in 2023 — This indicates how many shares 139.22 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Sensyne Health earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Sensyne Health's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Sensyne Health’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Sensyne Health's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Sensyne Health.

Sensyne Health shareholders

%
Name
Stocks
Change
Date
24.38698 % Lord Paul Radd Drayson40,594,57420,713,41211/15/2021
10.76815 % Lady Elspeth Drayson17,924,656480,0874/30/2021
8.07208 % Lansdowne Partners (UK) LLP13,436,78601/28/2022
6.62299 % Sand Grove Capital Management LLP11,024,6336,476,9091/28/2022
4.34437 % Gatemore Capital Management LLP7,231,64201/28/2022
3.39200 % Oxford University Hospitals NHS Foundation Trust5,646,32543,15511/11/2021
2.06960 % South Warwickshire NHS Foundation Trust3,445,050011/15/2021
2.06960 % Chelsea and Westminster Hospital NHS Foundation Trust3,445,050011/12/2021
1.38542 % Schroder Investment Management Ltd. (SIM)2,306,172011/2/2021
1.32240 % University of Oxford2,201,2752,201,27511/15/2021
1
2
3
4
5
...
10

Sensyne Health Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Microsoft Stock
Microsoft
SupplierCustomer0,250,660,480,89-0,21-0,10
Cognizant Tech A Stock
Cognizant Tech A
SupplierCustomer-0,290,650,52-0,45-0,85-0,12
Evotec Stock
Evotec
SupplierCustomer-0,370,700,550,910,750,46
Bristol-Myers Squibb Stock
Bristol-Myers Squibb
SupplierCustomer-0,400,37-0,86-0,86-0,42-0,20
Bayer Stock
Bayer
SupplierCustomer-0,520,22-0,79-0,79-0,67-0,49
Alexion Pharmaceuticals, Inc. Stock
Alexion Pharmaceuticals, Inc.
SupplierCustomer-0,77-0,47-0,87-0,83-0,90
Roche Holding Stock
Roche Holding
SupplierCustomer-0,850,69-0,440,28-0,30-0,42
1

Most common questions regarding Sensyne Health

What values and corporate philosophy does Sensyne Health represent?

Sensyne Health PLC is a leading healthcare technology company that focuses on improving patient outcomes. The company values innovation, collaboration, and ethical behavior in its pursuit of transforming healthcare through the use of artificial intelligence and clinical data analysis. Sensyne Health PLC strongly believes in the responsible and transparent use of patient data to drive breakthrough discoveries and enhance medical research. By partnering with the NHS and other healthcare organizations, Sensyne Health PLC aims to create value for patients, clinicians, and shareholders alike. With its commitment to putting patients at the center of its work, Sensyne Health PLC is dedicated to revolutionizing healthcare delivery for the benefit of all.

In which countries and regions is Sensyne Health primarily present?

Sensyne Health PLC is primarily present in the United Kingdom (UK). As a leading digital health technology company, Sensyne Health operates in various regions within the UK, including England, Scotland, Wales, and Northern Ireland. With its headquarters in Oxford, Sensyne Health focuses on delivering innovative solutions to drive improvements in patient care and health outcomes. By leveraging advanced analytics, artificial intelligence, and clinical expertise, Sensyne Health aims to transform the way healthcare is delivered and managed.

What significant milestones has the company Sensyne Health achieved?

Sensyne Health PLC, a prominent healthcare technology and artificial intelligence company, has achieved remarkable milestones throughout its journey. The company successfully secured a listing on the London Stock Exchange's Main Market in 2018. Moreover, it has entered into strategic collaborations with prestigious institutions like the University of Oxford and the South Warwickshire NHS Foundation Trust, bolstering its position in the healthcare industry. Sensyne Health has also gained recognition for its innovative data-driven solutions, focusing on improving patient outcomes and advancing precision medicine through machine learning algorithms. With an impressive track record, Sensyne Health PLC continues to make significant strides in transforming the healthcare landscape.

What is the history and background of the company Sensyne Health?

Sensyne Health PLC is a renowned healthcare technology company based in the United Kingdom. Established in 2018, the company specializes in the ethical application of clinical artificial intelligence to improve patient care and support medical research. Sensyne Health PLC collaborates with NHS Trusts and other healthcare organizations to develop secure, scalable, and regulatory-compliant digital health solutions. With a strong focus on data analysis, the company aims to harness the power of technology to enhance healthcare outcomes and expedite medical discoveries. Sensyne Health PLC continually strives to revolutionize the healthcare industry through innovation and transformative solutions.

Who are the main competitors of Sensyne Health in the market?

The main competitors of Sensyne Health PLC in the market are other companies operating in the digital healthcare sector, such as Cerner Corporation, Allscripts Healthcare Solutions Inc., and Teladoc Health Inc. These companies offer similar digital health solutions and technologies, competing directly with Sensyne Health in terms of product offerings and market share. Additionally, other established healthcare technology companies could also be considered as competitors, depending on the specific services they provide. However, Sensyne Health PLC maintains a unique position in the market with its proprietary artificial intelligence technology and data analysis capabilities.

In which industries is Sensyne Health primarily active?

Sensyne Health PLC primarily operates in the healthcare and technology industries.

What is the business model of Sensyne Health?

The business model of Sensyne Health PLC is focused on the development and application of artificial intelligence (AI) technology in healthcare. Sensyne Health combines clinical expertise with advanced data analytics to create new insights and solutions for the healthcare industry. By leveraging AI algorithms and machine learning, the company aims to unlock the value of patient data, enabling the discovery of novel insights and the development of innovative therapies and care pathways. Sensyne Health collaborates with patient groups, academic institutions, and healthcare providers to accelerate the development of personalized and data-driven healthcare solutions.

What is the P/E ratio of Sensyne Health 2024?

The Sensyne Health P/E ratio is 197.16.

What is the P/S ratio of Sensyne Health 2024?

The Sensyne Health P/S ratio is 0.01.

What is the Quality Investing of Sensyne Health?

The Quality Investing for Sensyne Health is 4/10.

What is the revenue of Sensyne Health 2024?

The expected Sensyne Health revenue is 75.76 M GBP.

How high is the profit of Sensyne Health 2024?

The expected Sensyne Health profit is 2,471.43 GBP.

What is the business model of Sensyne Health

Sensyne Health PLC is a leading digital health company that offers novel clinical decision support systems and artificial intelligence solutions for healthcare providers. With a focus on improving patient care through the application of data science, Sensyne Health provides personalized medical solutions tailored to the needs of patients, providers, and health systems.

What is the Sensyne Health dividend?

Sensyne Health pays a dividend of 0 GBP distributed over payouts per year.

How often does Sensyne Health pay dividends?

The dividend cannot currently be calculated for Sensyne Health or the company does not pay out a dividend.

What is the Sensyne Health ISIN?

The ISIN of Sensyne Health is GB00BYV3J755.

What is the Sensyne Health WKN?

The WKN of Sensyne Health is A2N38D.

What is the Sensyne Health ticker?

The ticker of Sensyne Health is SENS.L.

How much dividend does Sensyne Health pay?

Over the past 12 months, Sensyne Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sensyne Health is expected to pay a dividend of 0 GBP.

What is the dividend yield of Sensyne Health?

The current dividend yield of Sensyne Health is .

When does Sensyne Health pay dividends?

Sensyne Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sensyne Health?

Sensyne Health paid dividends every year for the past 0 years.

What is the dividend of Sensyne Health?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sensyne Health located?

Sensyne Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sensyne Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sensyne Health from 12/12/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 12/12/2024.

When did Sensyne Health pay the last dividend?

The last dividend was paid out on 12/12/2024.

What was the dividend of Sensyne Health in the year 2023?

In the year 2023, Sensyne Health distributed 0 GBP as dividends.

In which currency does Sensyne Health pay out the dividend?

The dividends of Sensyne Health are distributed in GBP.

All fundamentals about Sensyne Health

Our stock analysis for Sensyne Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sensyne Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.